发明名称 Oligomeric compounds for the modulation of survivin expression
摘要 Oligonucleotides directed against the survivin gene are provided for modulating the expression of survivin. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the survivin. Methods of using these compounds for modulation of survivin expression and for the treatment of diseases associated with either overexpression of survivin, expression of mutated survivin or both are provided. Examples of diseases are cancer such as lung, breast, colon, prostate, pancreas, lung, liver, thyroid, kidney, brain, testes, stomach, intestine, bowel, spinal cord, sinuses, bladder, urinary tract or ovaries cancers. The oligonucleotides may be composed of deoxyribonucleosides or a nucleic acid analogue such as for example locked nucleic acid or a combination thereof.
申请公布号 US8026355(B2) 申请公布日期 2011.09.27
申请号 US20100765673 申请日期 2010.04.22
申请人 SANTARIS PHARMA A/S;ENZON PHARMACEUTICALS, INC. 发明人 HANSEN JENS BO RODE;THRUE CHARLOTTE ALBAEK;WESTERGAARD MAJKEN;PETERSEN KAMILLE DUMONG;WISSENBACH MARGIT
分类号 C07H21/04 主分类号 C07H21/04
代理机构 代理人
主权项
地址